sirolimus

Immunosuppressive medicine used to prevent rejection of transplanted organs
Class type of: alkaloid, (32RS)-rapamycin Q32089

Facts

24 properties
Instance of
type of chemical entity
Part of
cellular response to rapamycin, response to rapamycin[7][8]
Active ingredient in
Rapamune
Canonical SMILES
CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC[5]
Chemical formula
C₅₁H₇₉NO₁₃[6]
Defined daily dose
3 mg
Isomeric SMILES
CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1O
Legal status (medicine)
boxed warning
Mass
913.555142 Da
NCI Thesaurus ID
C1212
Physically interacts with
FKBP prolyl isomerase 1A[4]
Pregnancy category
Australian pregnancy category C, US pregnancy category C
Stereoisomer of
LSM-6188, LSM-4886
World Health Organisation international non-proprietary name
sirolimus, sirólimus, sirolimusum
🏷️ Also known as
en WY-090217 en AY-22989 en (-)-rapamycin en rapamycin en sirolimus ar سيروليموس cs sirolimus da irsolimus de Rapamycin en-gb sirolimus en-gb AY-22989 en-gb WY-090217 es AY-22989 es rapamicina es rapamisina es sirólimus es WY-090217 fa سیرولیموس fi Rapamune fi Rapamysiini
🔖 Identifiers · 48
Library of Congress Authorities ID
sh2001005861
OpenAlex ID
C2777921159
ATC code
L04AA10, S01XA23
CAS Registry Number
53123-88-9
ChEBI ID
9168
ChEMBL ID
CHEMBL413
ChemSpider ID
10482078
DSSTOX compound identifier
DTXCID503582
DSSTox substance ID
DTXSID5023582
DeCS ID
33809
DrugBank ID
DB00877
Show all 48 identifiers +36
DrugCentral ID
2446
EC number
610-965-5
ECHA Substance Infocard ID
100.107.147
Encyclopædia Britannica Online ID
science/rapamycin
Freebase ID
/m/02m01g
Guide to Pharmacology Ligand ID
6031
HSDB ID
7284
J9U entity ID
987007542160305171
KEGG ID
C07909
KNApSAcK ID
C00018055
LIPID MAPS ID
LMPK06000003
MeSH descriptor ID
D020123
MeSH tree code
D02.540.505.760
MedlinePlus drug identifier
a602026
Microsoft Academic ID (discontinued)
2777921159
NDF-RT ID
N0000148624
NSC number
226080, 758664
Natural Product Atlas ID
NPA000414
Nikkaji ID
J137.896A
PDB ligand ID
RAP
PatientsLikeMe treatment ID
sirolimus
Probes And Drugs ID
PD003301
PubChem CID
5284616
RxNorm CUI
35302
SureChEMBL ID
3463
UNSPSC code
51201515
UniChem compound ID
123924
Wellcome Collection concept ID
muudk6xc
WikiProjectMed ID
Sirolimus
World Health Organisation international non-proprietary name numeric ID
7104

Report an error or request removal Lineage (PROV-JSON)

Press Enter · cited answer in seconds

Summary

sirolimus is a type of chemical entity[1]. sirolimus is a type of alkaloid[2] and (32RS)-rapamycin[3].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [4] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  2. [5] ↑ . PubChem. Retrieved . wikidata.org.
  3. [6] ↑ . PubChem. Retrieved . wikidata.org.
  4. [2] ↑ . wikidata.org.
  5. [3] ↑ . wikidata.org.
  6. [7] ↑ . Gene Ontology release 2019-11-16. wikidata.org.
  7. [8] ↑ . Gene Ontology release 2019-11-16. wikidata.org.
  8. [9] ↑ . DrugBank. Retrieved . newscientist.com. Provenance: wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . Incorporation of acetate, propionate, and methionine into rapamycin by Streptomyces hygroscopicus. wikidata.org.
  19. [20] ↑ . Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. wikidata.org.
  20. [21] ↑ . Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. wikidata.org.
  21. [22] ↑ . Leucinostatins from Ophiocordyceps spp. and Purpureocillium spp. Demonstrate Selective Antiproliferative Effects in Cells Representing the Luminal Androgen Receptor Subtype of Triple Negative Breast Cancer. wikidata.org.
  22. [23] ↑ . Leucinostatins from Ophiocordyceps spp. and Purpureocillium spp. Demonstrate Selective Antiproliferative Effects in Cells Representing the Luminal Androgen Receptor Subtype of Triple Negative Breast Cancer. wikidata.org.
  23. [24] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  24. [25] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  25. [26] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  26. [27] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  27. [28] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  28. [29] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  29. [30] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). sirolimus. Retrieved November 16, 2026, from https://4ort.xyz/entity/sirolimus
MLA “sirolimus.” 4ort.xyz Knowledge Graph, 4ort.xyz, 16 Nov. 2026, https://4ort.xyz/entity/sirolimus.
BibTeX @misc{4ortxyz_sirolimus_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{sirolimus}}, year = {2026}, url = {https://4ort.xyz/entity/sirolimus}, note = {Accessed: 2026-11-16}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): sirolimus — https://4ort.xyz/entity/sirolimus (retrieved 2026-11-16)

Canonical URL: https://4ort.xyz/entity/sirolimus · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 14d ago · Elivan da Silva · 2026-11-04 view diff on Wikidata ↗
    Inhibitor of → mechanistic target of rapamycin kinase
    Described at URL → https://www.newscientist.com/article/2516893-rapamycin-can-a, https://pmc.ncbi.nlm.nih.gov/articles/PMC12226543/, https://www.thelancet.com/journals/lanhl/article/PIIS2666-75 +1
    "Added reference: ATC code: S01XA23, #temporary_batch_1793797519273"
  2. 9w ago · Back ache · 2026-09-14 view diff on Wikidata ↗
    Described at URL → https://www.newscientist.com/article/2516893-rapamycin-can-a, https://pmc.ncbi.nlm.nih.gov/articles/PMC12226543/, https://www.thelancet.com/journals/lanhl/article/PIIS2666-75 +1
    "Created claim: Described at URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12226543/"
  3. 25w ago · Twofivesixbot bot · 2026-05-23 view diff on Wikidata ↗
    Described at URL → https://www.newscientist.com/article/2516893-rapamycin-can-a, https://pmc.ncbi.nlm.nih.gov/articles/PMC12226543/, https://www.thelancet.com/journals/lanhl/article/PIIS2666-75 +1
    "Changed claim qualifiers: J9U entity ID: 987007542160305171, mv to monolingual text names on J9U statements"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.